Heart disease is the leading cause of death in the U.S., claiming over 1,900 lives each day, according to the American Heart Association. Every year, February is recognised as American Heart Month to raise awareness about heart health. Meanwhile, several drugs are also scheduled for FDA review this February. Will they pass the regulatory muster, or will they be sent back to the drawing board?
Let's take a look at the biotech stocks facing the FDA decision next month.
For comments and feedback contact: editorial@rttnews.com
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.